Chronic administration of an oral Rho kinase inhibitor prevents the development of vasculogenic erectile dysfunction in a rat model. [electronic resource]
Producer: 20070309Description: 996-1003 p. digitalISSN:- 1743-6095
- 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine -- administration & dosage
- Animals
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Impotence, Vasculogenic -- drug therapy
- Intracellular Signaling Peptides and Proteins -- administration & dosage
- Male
- Penile Erection -- drug effects
- Protein Kinase Inhibitors -- administration & dosage
- Protein Serine-Threonine Kinases -- administration & dosage
- Random Allocation
- Rats
- Rats, Sprague-Dawley
- Vasodilator Agents -- administration & dosage
- rho-Associated Kinases
- rhoA GTP-Binding Protein -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.